Focal nodular hyperplasia after busulfan treatment

Dig Liver Dis. 2005 Aug;37(8):619-21. doi: 10.1016/j.dld.2004.09.031.

Abstract

The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described. Focal nodular hyperplasia is a reactive disorder related to a circulation disorder. The close temporal relation between the haematological disease, busulfan treatment and the appearance of hyperplastic diseases of the liver in our patient supports the possibility that the association of the events might not be casual.

Publication types

  • Case Reports

MeSH terms

  • Busulfan / administration & dosage
  • Busulfan / adverse effects*
  • Female
  • Focal Nodular Hyperplasia / chemically induced*
  • Focal Nodular Hyperplasia / diagnostic imaging
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Middle Aged
  • Thrombocytosis / drug therapy
  • Ultrasonography

Substances

  • Immunosuppressive Agents
  • Busulfan